ACS Reperfusion Strategy

ACS reperfusion strategy is one of the highest-yield management topics on USMLE Step 1. Students consistently anchor the 90-minute door-to-balloon target to symptom onset instead of first medical contact — but the clock starts when EMS arrives or the patient hits triage, and that distinction changes how you calculate and apply the time target on vignette questions. The core concept is straightforward — open the artery fast — but the exam doesn't just ask you to recall that. It tests whether you know the specific time targets, the reference points those targets are measured from, when to use fibrinolytics instead of PCI, and what happens after you give lytics.

What makes this topic tricky is the precision required. Students often know the 90-minute number but anchor it to the wrong reference point (symptom onset instead of first medical contact). They know fibrinolytics are contraindicated after stroke but apply that contraindication too broadly, missing the 3-month cutoff that separates absolute from relative contraindications. USMLE Step 1 exploits both of these gaps constantly.

The pharmacoinvasive strategy is where the biggest knowledge gap lives. Most students treat fibrinolytics as a 'give and watch' intervention — if the patient improves, you're done. That's wrong. Pharmacoinvasive strategy means lytics are bridge therapy, and routine angiography within 3–24 hours is mandatory regardless of whether reperfusion looks successful. Understanding this changes how you interpret entire vignette scenarios on the exam.